Condition: Recurrent Adult Acute Myeloid Leukemia · Myelodysplastic Syndrome · Adult Acute Myeloid Leukemia · Sponsor: Ruijin Hospital
The goal of this clinical trial\] is to evaluate mitoxantrone hydrochloride liposomes, subcutaneous injection of cytarabine and G-CSF combined with Venetoclax (CMG+Ven) in adult secondary acute myeloid leukemia and myelodysplastic syndrome with increased primordial cells type 2(MDS-IB2) or elderly acute myeloid leukemia\]. The main questions it aims to answer are: * Evaluation of the efficacy * Evaluation of the safety
This description comes directly from the study's public registry record.
Xiaoqian Xu, Doctor · 13816205940 · Ellenxxq@qq.com
sujiang Zhang, Doctor · Zbruce.zhang@hotmail.com
Always discuss trial participation with your own doctor first.
| Ruijin Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06329999